{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T21:10:22Z","timestamp":1774818622322,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015377","name":"Nihon Medi-Physics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.brachy.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T23:14:01Z","timestamp":1653606841000},"page":"626-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7579-0372","authenticated-orcid":false,"given":"Yasushi","family":"Nakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9242-7877","authenticated-orcid":false,"given":"Nobumichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuske","family":"Morizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Yamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunta","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makito","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Torimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2022.04.008_bib0001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2022.04.008_bib0002","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ijrobp.2010.01.006","article-title":"Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?","volume":"79","author":"Kuban","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.008_bib0003","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12885-017-3565-1","article-title":"Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer","volume":"17","author":"Tanaka","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.brachy.2022.04.008_bib0004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.008_bib0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2010.01.005","article-title":"Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy","volume":"79","author":"Taira","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.008_bib0006","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/bju.15003","article-title":"Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry","volume":"125","author":"Viktorin-Baier","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2022.04.008_bib0007","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","article-title":"Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique","volume":"110","author":"Murray","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2022.04.008_bib0008","doi-asserted-by":"crossref","first-page":"i851","DOI":"10.1136\/bmj.i851","article-title":"Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis","volume":"352","author":"Wallis","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.brachy.2022.04.008_bib0009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12885-020-06960-9","article-title":"Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up","volume":"20","author":"Vuolukka","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.brachy.2022.04.008_bib0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","article-title":"Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.008_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijrobp.2015.05.014","article-title":"Urinary and rectal toxicity profiles after permanent iodine-125 implant brachytherapy in Japanese men: nationwide J-POPS multi-institutional prospective cohort study","volume":"93","author":"Ohashi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.008_bib0012","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.brachy.2019.05.005","article-title":"Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer","volume":"18","author":"Vuolukka","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.04.008_bib0013","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ijrobp.2015.02.047","article-title":"Long-term efficacy and toxicity of low-dose-rate \u00b9\u00b2\u2075I prostate brachytherapy as monotherapy in low-, intermediate-, and high-risk prostate cancer","volume":"92","author":"Kittel","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.008_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.05.056","article-title":"Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05)","volume":"81","author":"Lawton","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0015","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/j.ijrobp.2011.11.040","article-title":"Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate","volume":"82","author":"Lawton","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/iju.14098","article-title":"Low-dose-rate brachytherapy for prostate cancer: a 15-year experience in Japan","volume":"27","author":"Tanaka","year":"2020","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.brachy.2022.04.008_bib0017","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.brachy.2019.03.007","article-title":"J-POPS Study Group. Genitourinary toxicity after permanent iodine-125 seed implantation: the nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)","volume":"18","author":"Tanaka","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.04.008_bib0018","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0022-5347(01)66256-6","article-title":"Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries","volume":"155","author":"Masumori","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.brachy.2022.04.008_bib0019","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ijrobp.2016.06.026","article-title":"Initial report of NRG Oncology\/RTOG 0232: a phase 3 study comparing combined external beam radiation and transperineal interstitial permanent brachytherapy with brachytherapy alone for selected patients with intermediate-risk prostatic carcinoma","volume":"96","author":"Prestidge","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.brachy.2015.12.011","article-title":"Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy","volume":"15","author":"Eriguchi","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.04.008_bib0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1748-717X-8-25","article-title":"Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy","volume":"8","author":"Tanaka","year":"2013","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.brachy.2022.04.008_bib0022","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijrobp.2011.06.2013","article-title":"Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer","volume":"83","author":"Forsythe","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0023","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0024","article-title":"Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low-dose-rate brachytherapy for localized prostate cancer","author":"Owari","year":"2021","journal-title":"Int J Urol"},{"key":"10.1016\/j.brachy.2022.04.008_bib0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.brachy.2016.09.001","article-title":"Predictive factors of rectal toxicity after permanent iodine-125 seed implantation: prospective cohort study in 2339 patients","volume":"15","author":"Katayama","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.04.008_bib0026","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s10147-020-01713-x","article-title":"Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy","volume":"25","author":"Taniguchi","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.brachy.2022.04.008_bib0027","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brachy.2008.12.001","article-title":"The effect of obesity on rectal dosimetry after permanent prostate brachytherapy","volume":"8","author":"Patil","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.04.008_bib0028","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0029","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijrobp.2013.04.047","article-title":"Novel parameter predicting grade 2 rectal bleeding after iodine-125 prostate brachytherapy combined with external beam radiation therapy","volume":"87","author":"Shiraishi","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0030","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.eururo.2011.05.052","article-title":"Late gastrointestinal toxicities following radiation therapy for prostate cancer","volume":"60","author":"Kim","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2022.04.008_bib0031","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2009.02.026","article-title":"External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?","volume":"76","author":"Choe","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0032","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0016-5085(90)90828-O","article-title":"The prevalence of hemorrhoids and chronic constipation. An epidemiologic study","volume":"9","author":"Johanson","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.brachy.2022.04.008_bib0033","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","article-title":"Johnell K An update on the clinical consequences of polypharmacy in older adults: a narrative review","volume":"17","author":"Wastesson","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.brachy.2022.04.008_bib0034","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.brachy.2016.06.005","article-title":"The risk of second malignancies after 125I prostate brachytherapy as monotherapy in a single Australian institution","volume":"15","author":"Fernandez Ots","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.04.008_bib0035","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1200\/JCO.2011.35.0991","article-title":"Prostate brachytherapy and second primary cancer risk: a competitive risk analysis","volume":"29","author":"Hinnen","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.brachy.2022.04.008_bib0036","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijrobp.2014.07.032","article-title":"Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy","volume":"90","author":"Hamilton","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2022.04.008_bib0037","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.juro.2006.10.071","article-title":"Bladder cancer incidence and risk factors in men with prostate cancer: results from cancer of the prostate strategic urologic research endeavor","volume":"177","author":"Boorjian","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.brachy.2022.04.008_bib0038","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12874-017-0367-8","article-title":"Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments","volume":"17","author":"Bolch","year":"2017","journal-title":"BMC Med Res Methodol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122000757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122000757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:17:25Z","timestamp":1761531445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472122000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1538472122000757"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2022.04.008","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}